Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -0.69% is 111% below its 5-year average of 6.20%, near the high end of its 5-year range (-49.50%–13.26%).
As of the fiscal period ended Tuesday, June 30, 2026. 98.22% above its 12-month average of -38.74%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -0.69%.
RETURN ON EQUITY (ROE)
-0.69%
RETURN ON EQUITY (ROE) AVG TTM
-38.74%
RETURN ON EQUITY (ROE) AVG 3Y
-13.38%
RETURN ON EQUITY (ROE) AVG 5Y
6.20%
RETURN ON EQUITY (ROE) AVG 10Y
5.91%
RETURN ON EQUITY (ROE) AVG 15Y
5.07%
RETURN ON EQUITY (ROE) AVG 20Y
6.72%
CURRENT VS TTM AVG
+98.22%
CURRENT VS 3Y AVG
+94.85%
CURRENT VS 5Y AVG
-111.12%
CURRENT VS 10Y AVG
-111.67%
CURRENT VS 15Y AVG
-113.61%
CURRENT VS 20Y AVG
-110.26%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+98.36%
vs the sector median at left
Integra LifeSciences Holdings Corporation
Market Cap
$1.04B
Return on Equity (ROE)
-0.69%
TTM Avg
-38.74%
3Y Avg
-13.38%
5Y Avg
6.20%
Market Cap
$1.03B
Return on Equity (ROE)
-4.51%
TTM Avg
-33.13%
3Y Avg
-42.62%
5Y Avg
-42.62%
Market Cap
$1.02B
Return on Equity (ROE)
-11.06%
TTM Avg
-9.32%
3Y Avg
-13.81%
5Y Avg
-2.96%
Market Cap
$1.05B
Return on Equity (ROE)
-13.54%
TTM Avg
-40.81%
3Y Avg
-170.75%
5Y Avg
-114.78%
Market Cap
$1.02B
Return on Equity (ROE)
-4.13%
TTM Avg
-0.56%
3Y Avg
-8.16%
5Y Avg
-7.12%
Market Cap
$1.01B
Return on Equity (ROE)
-52.47%
TTM Avg
-18.98%
3Y Avg
-16.96%
5Y Avg
-116.25%
Market Cap
$998.69M
Return on Equity (ROE)
-63.62%
TTM Avg
-41.08%
3Y Avg
-23.78%
5Y Avg
-22.76%
Market Cap
$996.65M
Return on Equity (ROE)
-32.27%
TTM Avg
-24.43%
3Y Avg
-32.70%
5Y Avg
-40.03%
Market Cap
$992.14M
Return on Equity (ROE)
N/A
TTM Avg
151.31%
3Y Avg
46.92%
5Y Avg
11.01%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corporation (IART) | $1.04B | -0.69% | -38.74% | -13.38% | 6.20% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.03B | -4.51% | -33.13% | -42.62% | -42.62% |
| Janux Therapeutics, Inc. (JANX)vs › | $1.02B | -11.06% | -9.32% | -13.81% | -2.96% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -13.54% | -40.81% | -170.75% | -114.78% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.02B | -4.13% | -0.56% | -8.16% | -7.12% |
| Immatics N.V. (IMTX)vs › | $1.01B | -52.47% | -18.98% | -16.96% | -116.25% |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $998.69M | -63.62% | -41.08% | -23.78% | -22.76% |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $996.65M | -32.27% | -24.43% | -32.70% | -40.03% |
| Vor Biopharma Inc. (VOR)vs › | $992.14M | N/A | 151.31% | 46.92% | 11.01% |
| IRadimed Corporation (IRMD)vs › | $1.08B | 22.66% | 22.95% | 21.85% | 17.09% |
ROE
-0.7%
ROA
-0.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -0.69% |
| 2026-03-31 | -47.56% |
| 2025-12-31 | -49.50% |
| 2025-09-30 | -47.74% |
| 2025-06-30 | -48.20% |
| 2025-03-31 | -1.90% |
| 2024-12-31 | -0.45% |
| 2024-09-30 | -0.43% |
| 2024-06-30 | 1.54% |
| 2024-03-31 | 2.52% |
| 2023-12-31 | 4.27% |
| 2023-09-30 | 6.39% |
| 2023-06-30 | 7.80% |
| 2023-03-31 | 10.26% |
| 2022-12-31 | 10.01% |
| 2022-09-30 | 10.03% |
| 2022-06-30 | 10.01% |
| 2022-03-31 | 9.69% |
| 2021-12-31 | 10.04% |
| 2021-09-30 | 13.26% |
| 2021-06-30 | 13.05% |
| 2021-03-31 | 11.12% |
| 2020-12-31 | 8.84% |
| 2020-09-30 | 4.04% |
| 2020-06-30 | -0.26% |
| 2020-03-31 | 1.98% |
| 2019-12-31 | 3.54% |
| 2019-09-30 | 4.33% |
| 2019-06-30 | 7.10% |
| 2019-03-31 | 5.91% |
| 2018-12-31 | 4.42% |
| 2018-09-30 | 5.86% |
| 2018-06-30 | 5.21% |
| 2018-03-31 | 6.94% |
| 2017-12-31 | 6.73% |
| 2017-09-30 | 5.33% |
| 2017-06-30 | 7.34% |
| 2017-03-31 | 7.92% |
| 2016-12-31 | 8.67% |
| 2016-09-30 | 7.23% |
| 2016-06-30 | 0.94% |
| 2016-03-31 | -0.03% |
| 2015-12-31 | -0.47% |
| 2015-09-30 | -0.18% |
| 2015-06-30 | 5.67% |
| 2015-03-31 | 5.84% |
| 2014-12-31 | 4.83% |
| 2014-09-30 | 4.23% |
| 2014-06-30 | -1.35% |
| 2014-03-31 | -1.58% |
| 2013-12-31 | -2.53% |
| 2013-09-30 | -3.28% |
| 2013-06-30 | 4.91% |
| 2013-03-31 | 5.97% |
| 2012-12-31 | 7.96% |
| 2012-09-30 | 6.26% |
| 2012-06-30 | 6.11% |
| 2012-03-31 | 4.56% |
| 2011-12-31 | 5.68% |
| 2011-09-30 | 8.42% |
| 2011-06-30 | 9.15% |
| 2011-03-31 | 11.74% |
| 2010-12-31 | 13.13% |
| 2010-09-30 | 13.30% |
| 2010-06-30 | 13.15% |
| 2010-03-31 | 12.36% |
| 2009-12-31 | 11.45% |
| 2009-09-30 | 13.96% |
| 2009-06-30 | 7.53% |
| 2009-03-31 | 8.80% |
| 2008-12-31 | 9.97% |
| 2008-09-30 | 4.81% |
| 2008-06-30 | 12.48% |
| 2008-03-31 | 12.45% |
| 2007-12-31 | 12.85% |
| 2007-09-30 | 15.26% |
| 2007-06-30 | 13.93% |
| 2007-03-31 | 9.75% |
| 2006-12-31 | 9.93% |
| 2006-09-30 | 9.78% |
| 2006-06-30 | 12.11% |
| 2006-03-31 | 12.12% |
| 2005-12-31 | 12.83% |
| 2005-09-30 | 11.84% |
| 2005-06-30 | 6.22% |
| 2005-03-31 | 5.79% |
| 2004-12-31 | 5.59% |
| 2004-09-30 | 5.65% |
| 2004-06-30 | 10.74% |
| 2004-03-31 | 10.38% |
| 2003-12-31 | 10.00% |
| 2003-09-30 | 17.43% |
| 2003-06-30 | 15.87% |
